Literature DB >> 21454491

Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors.

Derek N Lavery1, M Angeles Villaronga, Marjorie M Walker, Anup Patel, Borja Belandia, Charlotte L Bevan.   

Abstract

The Hairy/Enhancer-of-split-related with YRPW-like motif (HEY) family of proteins are transcriptional repressors and downstream effectors of Notch signaling. We previously reported that HEY1 and HEY2 selectively repress androgen receptor (AR) signaling in mammalian cell lines and have shown that in human tissue HEY1 is excluded from the nuclei in prostate cancer but not benign prostatic hyperplasia. We have now characterized a third member of this family, HEYL, which is a more potent repressor of AR activity. HEYL interacted with and repressed AR activation function-1 domain and competitively inhibited SRC1e activation of AR transcriptional activity. Using a cell line inducibly expressing exogenous HEYL, we showed that HEYL represses endogenous AR-regulated genes and reduces androgen-dependent prostate cancer cell growth. Using a trans-repression assay, we identified both trichostatin-sensitive and -insensitive domains within HEYL; however, analysis of endogenous AR target genes suggested that HEYL represses AR activity through histone deacetylase I/II-independent mechanisms. Immunohistochemical analyses of tissue indicated that, in a fashion similar to that previously reported for HEY1, HEYL is excluded from the nuclei in prostate cancer but not adjacent benign tissue. This suggests that nuclear exclusion of HEY proteins may be an important step in the progression of prostate cancer.
© 2011 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454491      PMCID: PMC3093855          DOI: 10.1074/jbc.M110.198655

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional control.

Authors:  Valerie Christiaens; Charlotte L Bevan; Leen Callewaert; Anna Haelens; Guy Verrijdt; Wilfried Rombauts; Frank Claessens
Journal:  J Biol Chem       Date:  2002-10-04       Impact factor: 5.157

2.  Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions.

Authors:  C J Loy; K S Sim; E L Yong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

3.  Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition.

Authors:  Andreas Fischer; Christian Steidl; Toni U Wagner; Esra Lang; Peter M Jakob; Peter Friedl; Klaus-Peter Knobeloch; Manfred Gessler
Journal:  Circ Res       Date:  2007-02-15       Impact factor: 17.367

Review 4.  Androgen receptor corepressors and prostate cancer.

Authors:  Craig J Burd; Lisa M Morey; Karen E Knudsen
Journal:  Endocr Relat Cancer       Date:  2006-12       Impact factor: 5.678

5.  The Notch target genes Hey1 and Hey2 are required for embryonic vascular development.

Authors:  Andreas Fischer; Nina Schumacher; Manfred Maier; Michael Sendtner; Manfred Gessler
Journal:  Genes Dev       Date:  2004-04-15       Impact factor: 11.361

Review 6.  Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family.

Authors:  Jianming Xu; Ray-Chang Wu; Bert W O'Malley
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

7.  Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression.

Authors:  G N Brooke; M G Parker; C L Bevan
Journal:  Oncogene       Date:  2007-11-26       Impact factor: 9.867

8.  Androgens target prohibitin to regulate proliferation of prostate cancer cells.

Authors:  Simon C Gamble; Michael Odontiadis; Jonathan Waxman; Jules A Westbrook; Michael J Dunn; Robin Wait; Eric W-F Lam; Charlotte L Bevan
Journal:  Oncogene       Date:  2004-04-15       Impact factor: 9.867

9.  Nuclear receptor regulation gears up another Notch.

Authors:  Borja Belandia; Malcolm G Parker
Journal:  Nucl Recept Signal       Date:  2006-02-08

10.  The role of androgen receptor mutations in prostate cancer progression.

Authors:  G N Brooke; C L Bevan
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

View more
  22 in total

1.  Divergent Binding and Transactivation by Two Related Steroid Receptors at the Same Response Element.

Authors:  Martina Tesikova; Xavier Dezitter; Hatice Z Nenseth; Tove I Klokk; Florian Mueller; Gordon L Hager; Fahri Saatcioglu
Journal:  J Biol Chem       Date:  2016-04-07       Impact factor: 5.157

2.  Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer.

Authors:  Loredana Puca; Katie Gavyert; Verena Sailer; Vincenza Conteduca; Etienne Dardenne; Michael Sigouros; Kumiko Isse; Megan Kearney; Aram Vosoughi; Luisa Fernandez; Heng Pan; Samaneh Motanagh; Judy Hess; Adam J Donoghue; Andrea Sboner; Yuzhuo Wang; Ryan Dittamore; David Rickman; David M Nanus; Scott T Tagawa; Olivier Elemento; Juan Miguel Mosquera; Laura Saunders; Himisha Beltran
Journal:  Sci Transl Med       Date:  2019-03-20       Impact factor: 17.956

Review 3.  Notch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology.

Authors:  Gang Deng; Libin Ma; Qi Meng; Xiang Ju; Kang Jiang; Peiwu Jiang; Zhijian Yu
Journal:  J Cancer Res Clin Oncol       Date:  2015-03-04       Impact factor: 4.553

4.  Transcriptomic diversification of developing cumulus and mural granulosa cells in mouse ovarian follicles.

Authors:  Karen Wigglesworth; Kyung-Bon Lee; Chihiro Emori; Koji Sugiura; John J Eppig
Journal:  Biol Reprod       Date:  2014-11-05       Impact factor: 4.285

5.  Stem Cell Antigen-1 Identifies a Distinct Androgen-Independent Murine Prostatic Luminal Cell Lineage with Bipotent Potential.

Authors:  Oh-Joon Kwon; Li Zhang; Li Xin
Journal:  Stem Cells       Date:  2015-10-27       Impact factor: 6.277

Review 6.  miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.

Authors:  Sundas Fayyaz; Ammad Ahmad Farooqi
Journal:  Immunogenetics       Date:  2013-04-05       Impact factor: 2.846

7.  Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.

Authors:  Oh-Joon Kwon; Li Zhang; Jianghua Wang; Qingtai Su; Qin Feng; Xiang H F Zhang; Sendurai A Mani; Robia Paulter; Chad J Creighton; Michael M Ittmann; Li Xin
Journal:  J Clin Invest       Date:  2016-06-13       Impact factor: 14.808

Review 8.  Notch signaling in prostate cancer: refining a therapeutic opportunity.

Authors:  Qingtai Su; Li Xin
Journal:  Histol Histopathol       Date:  2015-11-02       Impact factor: 2.303

9.  High expression of TREM2 promotes EMT via the PI3K/AKT pathway in gastric cancer: bioinformatics analysis and experimental verification.

Authors:  Chunmei Li; Xiaoming Hou; Shuqiao Yuan; Yigan Zhang; Wenzhen Yuan; Xiaoguang Liu; Juan Li; Yuping Wang; Quanlin Guan; Yongning Zhou
Journal:  J Cancer       Date:  2021-04-02       Impact factor: 4.207

Review 10.  Disruption of prostate epithelial differentiation pathways and prostate cancer development.

Authors:  Sander B Frank; Cindy K Miranti
Journal:  Front Oncol       Date:  2013-10-31       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.